Cargando…

Circulating Tumor-Derived Endothelial Cells: An Effective Biomarker for Breast Cancer Screening and Prognosis Prediction

BACKGROUND: Circulating tumor-derived endothelial cell (CTEC) is a new potential tumor biomarker to be associated with cancer development and treatment efficacy. However, few evidences are available for breast cancer. METHODS: Eighty-nine breast cancer patients were recruited, and preoperative and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Tuo, Zhang, Juanjuan, Xiao, Dong, Yang, Binhui, Chen, Liang, Zhai, Chao, Ding, Feifei, Xu, Yue, Zhao, Xiaoyu, Zhao, Jiangman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441390/ https://www.ncbi.nlm.nih.gov/pubmed/36072971 http://dx.doi.org/10.1155/2022/5247423

Ejemplares similares

Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report
por: Su, Zijian, et al.
Publicado: (2018)

Screening of biomarkers for prediction of response to and prognosis after chemotherapy for breast cancers
por: Bing, Feng, et al.
Publicado: (2016)

Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9
por: Luo, Shimu, et al.
Publicado: (2021)

Genetic Profiling of Breast Cancer with and Without Preexisting Metabolic Disease
por: Jing, Wenjiang, et al.
Publicado: (2019)

Tumor-Derived circRNAs as Circulating Biomarkers for Breast Cancer
por: Yu, Yunhe, et al.
Publicado: (2022)

Serum peptidomic screening identified circulating peptide biomarkers predictive for preeclampsia
por: Zhao, Shenglong, et al.
Publicado: (2022)

Circulating endothelial cells as biomarker for cardiovascular diseases
por: Farinacci, Maura, et al.
Publicado: (2018)

Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer
por: Chen, Jing, et al.
Publicado: (2020)

Accuracy of Tumour-Associated Circulating Endothelial Cells as a Screening Biomarker for Clinically Significant Prostate Cancer
por: Bhakdi, Sebastian Chakrit, et al.
Publicado: (2019)

The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2023)

PW01-018 – Circulating endothelial biomarkers in FMF
por: Sari, I, et al.
Publicado: (2013)

Circulating Biomarkers of Inflammation and Endothelial Activation in Diabetic Retinopathy
por: Storti, Federica, et al.
Publicado: (2021)

Increased Circulating MicroRNA-155 as a Potential Biomarker for Breast Cancer Screening: A Meta-Analysis
por: Wang, Faliang, et al.
Publicado: (2014)

Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS
por: Hendrickson, Carolyn M., et al.
Publicado: (2018)

Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer
por: Li, Jiaying, et al.
Publicado: (2023)

Effect of Local Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Subcutaneously Allotransplanted Ovarian Tissue in Ovariectomized Mice
por: Gao, Jiangman, et al.
Publicado: (2015)

Circulating DNA as biomarker in breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2015)

Circulating Biomarkers of Colorectal Cancer (CRC)—Their Utility in Diagnosis and Prognosis
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model
por: Lin, Yuxin, et al.
Publicado: (2018)

Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity
por: Yang, Xiao, et al.
Publicado: (2022)

Development of Machine Learning Tools for Predicting Coronary Artery Disease in the Chinese Population
por: Zhang, Tiexu, et al.
Publicado: (2022)

In Silico Screening of Circulating MicroRNAs as Potential Biomarkers for the Diagnosis of Ovarian Cancer
por: Wu, Lei, et al.
Publicado: (2019)

Circulating miRNAs in Breast Cancer Diagnosis and Prognosis
por: Cardinali, Barbara, et al.
Publicado: (2022)

Circulating tRNA-derived small RNAs (tsRNAs) signature for the diagnosis and prognosis of breast cancer
por: Wang, Jingyi, et al.
Publicado: (2021)

Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia
por: Wang, Huiping, et al.
Publicado: (2020)

Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer
por: Wang, Yaohui, et al.
Publicado: (2018)

Brain-derived circulating endothelial cells in peripheral blood of newborn infants with seizures: a potential biomarker for cerebrovascular injury
por: Pourcyrous, Massroor, et al.
Publicado: (2015)

Screening circulating proteins to identify biomarkers of fetal macrosomia
por: Cruickshank, Tess, et al.
Publicado: (2019)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
por: Hong, Yang, et al.
Publicado: (2021)

CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease
por: Dai, Ruozhu, et al.
Publicado: (2022)

Circulating endothelial microparticles: a promising biomarker of acute kidney injury after cardiac surgery with cardiopulmonary bypass
por: Ma, Jian, et al.
Publicado: (2021)

Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence
por: Rhone, Piotr, et al.
Publicado: (2019)

Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis
por: Li, Haoran, et al.
Publicado: (2022)

Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma
por: Uzawa, Katsuhiro, et al.
Publicado: (2012)

Circulating nucleic acids as biomarkers in breast cancer
por: Schwarzenbach, Heidi
Publicado: (2013)

Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis
por: Cho, William C. S.
Publicado: (2011)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
por: Alves dos Santos, Katiusse, et al.
Publicado: (2020)

Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico
por: Álvarez-Hilario, Lissuly Guadalupe, et al.
Publicado: (2023)

Circulating Neutrophil-Derived Microparticles Associated with the Prognosis of Patients with Sepsis
por: Chen, Hong-Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uud420h2t1fpvedo66ru8qnlvi